Oxford Square Capital Corp. is a business development company, operates as a closed-end, non-diversified management investment company. It is a private equity and mezzanine firm. The firm invests in both public and private companies. It invests in secured and unsecured senior debt, subordinated debt, junior subordinated debt, preferred stock, common stock and syndicated bank loans.
Read More…
Industry, Sector and Symbol
Industry Investment offices, not elsewhere classified
Sub-IndustryN/A
SectorFinance
CIKN/A
Phone203-983-5275
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$56.28 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date10/29/2019 (Estimated)
OptionableOptionable
Oxford Square Capital (NASDAQ:OXSQ) Frequently Asked Questions
What is Oxford Square Capital's stock symbol?
Oxford Square Capital trades on the NASDAQ under the ticker symbol "OXSQ."
How often does Oxford Square Capital pay dividends? What is the dividend yield for Oxford Square Capital?
Oxford Square Capital announced a dividend on Tuesday, July 30th. Shareholders of record on Monday, October 21st will be paid a dividend of $0.067 per share on Thursday, October 31st. The ex-dividend date of this dividend is Friday, October 18th. View Oxford Square Capital's Dividend History.
How were Oxford Square Capital's earnings last quarter?
Oxford Square Capital Corp (NASDAQ:OXSQ) issued its quarterly earnings results on Tuesday, July, 30th. The company reported $0.27 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.18 by $0.10. The company had revenue of $20.91 million for the quarter. Oxford Square Capital had a negative net margin of 34.20% and a positive return on equity of 11.75%. View Oxford Square Capital's Earnings History.
When is Oxford Square Capital's next earnings date?
What price target have analysts set for OXSQ?
3 brokerages have issued twelve-month price targets for Oxford Square Capital's stock. Their predictions range from $5.00 to $5.00. On average, they expect Oxford Square Capital's stock price to reach $5.00 in the next twelve months. This suggests that the stock has a possible downside of 16.4%. View Analyst Price Targets for Oxford Square Capital.
What is the consensus analysts' recommendation for Oxford Square Capital?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oxford Square Capital in the last year. There are currently 2 sell ratings and 1 hold rating for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Oxford Square Capital.
What are Wall Street analysts saying about Oxford Square Capital stock?
Here are some recent quotes from research analysts about Oxford Square Capital stock:
- 1. According to Zacks Investment Research, "Oxford Square Capital Corp. is a business development company principally investing in syndicated bank loans and debt and equity tranches of CLO vehicles. Oxford Square Capital Corp., formerly known as TICC Capital Corp., is based in Greenwich, United States. " (7/9/2019)
- 2. National Securities analysts commented, "▪ Oxford posted core NII/share of $0.20 compared to our estimate of $0.19. The core NII is, as expected, far lower than 4Q18 when market dislocation increased core NII to $0.34 per share. As a reminder, we add back CLO equity cost reductions (which is cash flow in excess of GAAP effective yield assumptions) to NII to arrive at our core figures. This dipped to $1.4mm (compared to our estimate of $1.2mm) from $7.9mm the quarter prior.
▪ NAV/share was up a modest $0.07/share Q/Q to $6.67 despite a significant rally in loan prices with the average bid up over 4% on the quarter after sliding 5.8% Q/Q for the 12/31/18 quarter. We understand that CLO equity prices remain depressed, with a good deal of the market still under 60% of cost despite loan prices rebounding. However, what strikes us as odd is that the roughly 62% of the portfolio in BSL and club deals wasn’t marked up. Senior secured notes depreciated by $4.0mm after depreciating by $8.5mm in 4Q18. This has to be due to idiosyncratic credit issues; or one would think. Yet loans ranked “3” actually decreased Q/Q to 8.7% from 10.6%. Spreads narrowed materially, so the marks aren’t technical, but the internal rankings are showing net improvement in individual credit so we are puzzled by this.
▪ The portfolio at cost finished 1Q19 at $483.4mm, down from $496.4mm Q/Q. In April, Oxford issued $44.8mm (including partial exercise of overallotment) of seven-year notes at a 6.25% coupon. On the call, management noted that the proceeds will be used to fund investments rather than pay-down the credit facility. While there has not been leverage guidance provided by management, we do not expect D/E to go much above 1.00x as CLO equity runs at around a third of the portfolio and is leveraged 10x and we expect the company doesn’t want economic leverage running too high.
▪ The loan market dislocation we expect in 2H19 will likely cause NAV to decline materially (although core NII should increase significantly) and, as they have in the past, we think market participants will likely sell a company whose portfolio is roughly a third long volatility (in CLO equity) due to technical marks.
▪ We are maintaining our SELL rating and $5 price target. We are revising our 2019 core NII/share estimate to $0.98 from $0.93 and our 2020 core NII/share estimate to $0.81 from $0.80." (5/6/2019)
Has Oxford Square Capital been receiving favorable news coverage?
Media stories about OXSQ stock have trended very negative on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Oxford Square Capital earned a daily sentiment score of -3.2 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Oxford Square Capital.
Are investors shorting Oxford Square Capital?
Oxford Square Capital saw a decrease in short interest in September. As of September 15th, there was short interest totalling 447,200 shares, a decrease of 9.6% from the August 15th total of 494,500 shares. Based on an average trading volume of 154,300 shares, the short-interest ratio is currently 2.9 days. Approximately 1.0% of the shares of the stock are sold short. View Oxford Square Capital's Current Options Chain.
Who are some of Oxford Square Capital's key competitors?
Some companies that are related to Oxford Square Capital include Apollo Investment (AINV), Tortoise Energy Infrastructure (TYG), AllianceBernstein Global Hgh Incm Fd (AWF), PIMCO High Income Fund (PHK), Blackrock Muniyield Insured Fund (MYI), General American Investors (GAM), Solar Capital (SLRC), Invesco Van Kampen Munpl Oprtnty Tr (VMO), Templeton Global Income Fund (GIM), Goldman Sachs BDC (GSBD), Tekla Healthcare Investors (HQH), Invesco Trust for Investment GradeMncpls (VGM), Blackrock Muniyield Fund (MYD), Invesco Municipal Trust (VKQ) and Templeton Dragon Fund (TDF).
What other stocks do shareholders of Oxford Square Capital own?
Who are Oxford Square Capital's key executives?
Oxford Square Capital's management team includes the folowing people:
- Mr. Jonathan H. Cohen, CEO & Interested Director (Age 54)
- Mr. Saul Barak Rosenthal, Pres & COO (Age 50)
- Mr. Bruce L. Rubin, CFO, Treasurer & Sec. (Age 60)
- Mr. Eli Smoroda, Sr. Accounting Mang.
- Mr. Gerald Cummins, Chief Compliance Officer (Age 64)
Who are Oxford Square Capital's major shareholders?
Oxford Square Capital's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Selz Capital LLC (0.33%), DNB Asset Management AS (0.30%) and CIBC Private Wealth Group LLC (0.16%). Company insiders that own Oxford Square Capital stock include Jonathan H Cohen and Saul B Rosenthal. View Institutional Ownership Trends for Oxford Square Capital.
Which institutional investors are selling Oxford Square Capital stock?
Which institutional investors are buying Oxford Square Capital stock?
OXSQ stock was bought by a variety of institutional investors in the last quarter, including DNB Asset Management AS. Company insiders that have bought Oxford Square Capital stock in the last two years include Jonathan H Cohen and Saul B Rosenthal. View Insider Buying and Selling for Oxford Square Capital.
How do I buy shares of Oxford Square Capital?
Shares of OXSQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Oxford Square Capital's stock price today?
One share of OXSQ stock can currently be purchased for approximately $5.98.
How big of a company is Oxford Square Capital?
Oxford Square Capital has a market capitalization of $284.95 million and generates $56.28 million in revenue each year. The company earns $-9,210,000.00 in net income (profit) each year or $0.67 on an earnings per share basis. View Additional Information About Oxford Square Capital.
What is Oxford Square Capital's official website?
How can I contact Oxford Square Capital?
Oxford Square Capital's mailing address is 8 SOUND SHORE DR SUITE 255, GREENWICH CT, 06830. The company can be reached via phone at 203-983-5275 or via email at [email protected]
MarketBeat Community Rating for Oxford Square Capital (NASDAQ OXSQ)
MarketBeat's community ratings are surveys of what our community members think about Oxford Square Capital and other stocks. Vote "Outperform" if you believe OXSQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OXSQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
